Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 7Liver Neoplasms 1

Interventions

Hepatectomy 10Blood Specimen Collection 9Sorafenib 7Polymerase Chain Reaction 4Biopsy 4regorafenib 3Mass Spectrometry 3Liver Transplantation 3Immunohistochemistry 3Chemoembolization, Therapeutic 3Walking Speed 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Imaging 2Gene Expression Profiling 2Bevacizumab 2trastuzumab deruxtecan 1taxane 1spartalizumab 1sintilimab 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1carmofur 1camrelizumab 1cabozantinib 1atezolizumab 1apatinib 1anlotinib 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Liver Neoplasms × cabozantinib × Clear all
NCT05100082 2025-12-30

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Takeda

Completed
263 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡